69 Results

People

  1. Yahalom
    Yahalom
  2. Moskowitz
    Moskowitz
  3. Zelenetz
    Zelenetz
  4. Moskowitz
    Moskowitz
  5. Noy
    Noy
  6. Portlock
    Portlock
  7. Horwitz
    Horwitz
  8. Hamlin
    Hamlin
  9. Matasar
    Matasar
  10. Nimer
    Nimer

Groups

  1. Department of Medicine (69)
  2. Nursing (69)
  3. Radiation Oncology, Department of (69)
  4. Survivorship Research (58)
  5. Center for Hematologic Malignancies (40)
  6. Hematologic Malignancies, Division of (40)
  7. Epidemiology and Biostatistics (32)
  8. Lymphoma (31)
  9. Solid Tumor Oncology Division (30)
  10. Biostatistics Service (26)
  1. "Department of Medicine"
  2. "Nursing"
  3. "Radiation Oncology, Department of"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (32)
  3. Conference Paper (1)
  4. Review (1)
Groups
  1. Department of Medicine (69)
  2. Nursing (69)
  3. Radiation Oncology, Department of (69)
  4. Survivorship Research (58)
  5. Center for Hematologic Malignancies (40)
  6. Hematologic Malignancies, Division of (40)

More Groups

People
  1. Joachim Yahalom (34)
  2. Craig Moskowitz (29)
  3. Andrew Zelenetz (27)
  4. Alison Moskowitz (17)
  5. Ariela Noy (17)
  6. David Straus (17)

More People

Years
  1. 2023 (4)
  2. 2022 (3)
  3. 2021 (6)
  4. 2020 (4)
  5. 2019 (4)
  6. 2018 (1)

More Years

Publications
  1. Blood (24)
  2. International Journal of Radiation Oncology, Biology, Physics (9)
  3. Journal of Clinical Oncology (9)
  4. British Journal of Haematology (3)
  5. New England Journal of Medicine (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Elsevier Inc. (12)
  3. American Society of Clinical Oncology (9)
  4. John Wiley & Sons (3)
  5. Oxford University Press (3)
  6. Massachusetts Medical Society (2)

More Publishers

Results (69)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Meeting Abstract

    Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Stadler, Z.; Yaeger, R.; Smith, J. J.; Saltz, L.; Widmar, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
    Journal Article

    DeWolf, S.; Elhanati, Y.; Nichols, K.; Waters, N. R.; Nguyen, C. L.; Slingerland, J. B.; Rodriguez, N.; Lyudovyk, O.; Giardina, P. A.; Kousa, A. I.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations: Results from the dose-escalation cohort
    Meeting Abstract

    Yang, J.; Mann, J.; Pike, L.; Zinovoy, M.; Young, R.; Offin, M.; Mitchell, R.; Kazarian, A.; Shadat, T.; Garner, J.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer
    Journal Article

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Lamendola-Essel, M.; El Dika, I. H.; Segal, N.; Shcherba, M.; Sugarman, R.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Oropharyngeal cancer early outcomes and challenges during the COVID-19 pandemic
    Meeting Abstract

    Kang, J. J.; Wu, Y.; Rybkin, A.; Yu, Y.; Chen, L.; Zakeri, K.; McBride, S.; Riaz, N.; Tsai, C. J.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Development and pilot implementation of a remote monitoring system for acute toxicity using electronic patient-reported outcomes for patients undergoing radiation therapy for breast cancer
    Journal Article

    Lapen, K.; Sabol, C.; Tin, A. L.; Lynch, K.; Kassa, A.; Mabli, X.; Ford, J.; Cha, E.; Bernstein, M. B.; Braunstein, L. Z.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save